Skip to main content
Beat Cancer EU Website Logo
Programmes de soutien scolaire et éducatif pour les patients en oncologie pédiatrique et les survivants : Une revue systématique des preuves et des recommandations pour la recherche et la pratique futures
ÉducationAllArticle

Programmes de soutien scolaire et éducatif pour les patients en oncologie pédiatrique et les survivants : Une revue systématique des preuves et des recommandations pour la recherche et la pratique futures

Une étude qui évalue l'importance des programmes de soutien scolaire et éducatif pour les patients et les survivants de l'oncologie pédiatrique

Année :2020

Support for Paediatric Oncology patients

When children, adolescents or young adults suffer from cancer, in many cases they can only attend their school or education to a limited extent or, at times, not at all. Therefore, special programmes are needed to provide targeted educational support to these young affected people during and after an illness.

In a systematic study, such support programmes were closely examined: 20 programmes were studied, of which 12 were school re‐entry
programmes (SRPs). Out of these, only three programmes met all the important evaluation criteria and it is not yet clear whether these programmes bring evident support – nevertheless, they are promising and further development work in this direction is needed in order to be able to offer the best possible programmes.

These following points, which the authors recommend, are particularly important:
Ensure education support services are available to all cancer patients
Provide details about programme content, timing, and materials to enhance implementation
Ground programmes in appropriate theory and modelled outcomes and utilise rigorous methods of evaluation
Adapt programmes to local contexts to support implementation

Discussion & Questions

Remarque : Les commentaires servent uniquement à la discussion et à la clarification. Pour des conseils médicaux, veuillez consulter un professionnel de santé.

Laisser un commentaire

Minimum 10 caractères, maximum 2000 caractères

Aucun commentaire pour le moment

Soyez le premier à partager vos réflexions !